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Abstract
Background: Fat mass and obesity (FTO) and melanocortin-4 receptor (MC4R) and are relevant genes associated with
obesity. This could be through food intake, but results are contradictory. Modulation by diet or other lifestyle factors is also
not well understood.
Objective: To investigate whether MC4R and FTO associations with body-weight are modulated by diet and physical activity
(PA), and to study their association with alcohol and food intake.
Methods: Adherence to Mediterranean diet (AdMedDiet) and physical activity (PA) were assessed by validated questionnaires
in 7,052 high cardiovascular risk subjects. MC4R rs17782313 and FTO rs9939609 were determined. Independent and joint
associations (aggregate genetic score) as well as statistical and biological gene-lifestyle interactions were analyzed.
Results: FTO rs9939609was associated with higher bodymass index (BMI), waist circumference (WC) and obesity (P,0.05 for all).
A similar, but not significant trend was found for MC4R rs17782313. Their additive effects (aggregate score) were significant and
we observed a 7% per-allele increase of being obese (OR=1.07; 95%CI 1.01–1.13). We found relevant statistical interactions
(P,0.05) with PA. So, in active individuals, the associations with higher BMI, WC or obesity were not detected. A biological (non-
statistical) interaction between AdMedDiet and rs9939609 and the aggregate score was found. Greater AdMedDiet in individuals
carrying 4 or 3-risk alleles counterbalanced their genetic predisposition, exhibiting similar BMI (P=0.502) than individuals with no
risk alleles and lower AdMedDiet. They also had lower BMI (P=0.021) than their counterparts with low AdMedDiet. We did not
find any consistent association with energy or macronutrients, but found a novel association between these polymorphisms and
lower alcohol consumption in variant-allele carriers (B+/2SE: 20.57+/20.16 g/d per-score-allele; P = 0.001).
Conclusion: Statistical and biological interactions with PA and diet modulate the effects of FTO and MC4R polymorphisms
on obesity. The novel association with alcohol consumption seems independent of their effects on BMI.
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Introduction
Early prediction of obesity risk will be facilitated by the
identification of the main genes and their relevant genetic variants.
However, the next step involving more successful obesity
prevention and therapy will better achieve after learning how
the phenotypic expression of the relevant genetic variants are
modulated by pertinent lifestyle factors such as dietary intake and
physical activity in order to reduce the manifestation of obesity in
genetically predisposed individuals. Outstanding among the many
genes associated with obesity is the fat mass and obesity gene
(FTO). It was the first locus discovered to be associated with BMI
and obesity risk [1]. One year after, a meta-analysis of several
genome wide association studies GWAs [2], established that the
second most important locus associated with BMI was the
melanocortin-4 receptor gene (MC4R). Previous studies had
already identified various rare mutations in the MC4R as the
commonest cause of monogenic forms of early-onset obesity [3,4].
Of the various polymorphisms found both in the FTO and in the
MC4R loci, the most significant are rs9939609 and rs17782313,
respectively [1,2,4]. The minor allele of the rs9939609 (C.A), has
been consistently associated with higher BMI and obesity risk
[1,5–8]. In a meta-analysis of population-based studies [1], the
per-A allele odds ratio (OR) for obesity was 1.31 [95% confidence
interval (CI): 1.23–1.39]. Although the minor allele of the
rs17782313 (T.C), has also been significantly associated with
greater BMI [2,4,9–11], its relevance in terms of the magnitude of
the association is considered smaller than that of FTO polymor-
phism, being the per-allele OR for obesity of 1.12 (95% CI: 1.08–
1.16) in the initial meta-analysis [2]. A few studies have also jointly
analyzed the FTO and MC4R polymorphisms, describing their
additive effects on obesity related variables [1,9,12,13]. Thus in a
European population, Cauchi et al [13] found that, compared to
participants carrying neither FTO nor MC4R risk allele, subjects
with three or four risk alleles had a 1.8-fold increased obesity risk.
The mechanism by which these polymorphisms may be
associated with greater BMI is unknown, but some studies on
animals have suggested that for both of them it could be through a
higher food intake [14–16]. However, human studies investigating
the associations of these polymorphisms with dietary intake are
scarce and contradictory [17–26]. Although initial studies [17–19]
have reported that FTO polymorphisms were associated with
higher fat and energy intake in carriers of the variant alleles, other
studies have not been able to replicate these associations [20–23].
Studies on the MC4R locus are few and also divergent [23–26],
requiring more research. Likewise, whereas several studies have
found an important statistical interaction with physical activity for
the FTO locus, so that greater physical activity attenuates the
increasing effects of the A-allele on BMI [27–29], for the MC4R
polymorphism there are hardly any studies that have analyzed this
interaction [30,31].
Although recently several studies analyzed the possible modu-
lation of the effects of the FTO polymorphisms on BMI through
diet, the results are still differing [22,32–35]. This, and the lack of
studies focused on gene-diet interactions of the MC4R polymor-
phism, make it necessary to carry out new research on these gene-
diet interactions considering both loci jointly. Moreover, although
the vast majority of studies have focused on statistical interactions
[36,37], we also have the so-called ‘‘biological interactions’’ in
which environmental factors could modify genetic susceptibility
without the interaction term in the mathematical model being
statistically significant [36–39]. Hence our aims were: 1) To
analyze the associations of the MC4R rs17782313 and FTO
rs9939609 polymorphisms with BMI and their modulation by
physical activity and diet, including the overall adherence to the
Mediterranean diet (MedDiet) pattern; 2) To study whether these
polymorphisms have an influence on food and alcohol intake in a
high cardiovascular risk population.
Methods
Subjects
We included 7,052 participants (3,008 men and 4,044 women)
from the PREDIMED (PREvencio´n con DIeta MEDiterra´nea)
study from whom DNA was isolated, the FTO polymorphism
(rs9939609) determined, and who had valid data for the main
clinical and lifestyle variables analyzed at baseline. In 7,019 of
them, the MC4R rs17782313 polymorphism was successfully
determined. The PREDIMED study is a multi-center clinical trial
(controlled-trials.com number, ISRCTN35739639) aimed at
assessing the effects of the MedDiet on the primary prevention
of cardiovascular disease [40]. The 7,052 participants analyzed
here did not differ in the main characteristics from those of the
total cohort (n = 7,447). Details of the PREDIMED Study have
been fully described elsewhere [41]. Briefly, from October 2003
potential high cardiovascular risk subjects were selected by
physicians in Primary Care Centers. Eligible subjects were
community-dwelling people (55–80 years of age for men; 60–80
years of age for women) who fulfilled at least one of two criteria:
Type 2 diabetes; 3 or more cardiovascular risk factors (hyperten-
sion, dyslipidemia, body mass index [BMI] $25 kg/m2, current
smoking, or a family history of premature cardiovascular disease).
The specific cut-off points for these eligibility criteria have been
previously described [41]. Type 2 diabetes was diagnosed
according to American Diabetes Association criteria [42].
Exclusion criteria included a personal history of cardiovascular
disease, any severe chronic illness, and drug or alcohol addiction
[41]. Participants were randomly assigned to three interventions
[41]. In this study we analyzed data at baseline. The Institutional
Review Board/Ethics Committee of each participating center
(University of Valencia, Valencia; Municipal Institut for Medical
Research, Barcelona; University Rovira i Virgili, Reus; University
of Navarra, Pamplona; Hospital Primary Care Division of Sevilla,
San Pablo Health Center, Sevilla; University of Las Palmas de
Gran Canaria, Las Palmas de Gran Canaria; University of
Barcelona, Barcelona; University of Malaga; Ma´laga; Hospital
Son Dureta, Palma de Mallorca; Hospital Universitario de
Bellvitge, Hospitalet de Llobregat, Barcelona and Institut d’In-
vestigacions Biome`diques August Pi Sunyer (IDIBAPS), Hospital
Clinic, Barcelona, Spain) approved the study protocol. All
participants provided written informed consent.
Demographic, Clinical, Anthropometric and Dietary
Measurements
The baseline examination included assessment of standard
cardiovascular risk factors, medication use, socio-demographic
factors and lifestyle variables, as previously detailed [41]. Food
intake and alcoholic beverage consumption, including wine, beer,
and spirits, were assessed through a validated semi-quantitative
137-item food frequency questionnaire [43]. Energy and nutrient
intake were calculated from Spanish food composition tables [44].
We calculated alcohol intake (g/d) for each individual on the basis
of the type and amount of alcoholic beverages by multiplying the
amount of the beverage (mL) by the respective grade (% alcohol)
and the constant 0.80 to transform alcohol volumes into weight. In
addition, three groups of alcohol consumption were defined
according to the reported daily intake of alcohol: no intake (0 g/d),
moderate intake (,26.4 g/d for men and ,13.2 g/d for women),
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and high intake (26.4 g/d for men and 13.2 g/d for women).
These gram amounts correspond to 1 drink/d for women and 2
drinks/d for men [45].
The baseline examination also included the administration of a
validated 14-item questionnaire indicating the degree of adherence
to the traditional MedDiet [46]. This screener consists of 14
questions on food consumption frequency and on food intake
habits considered characteristic of the Spanish MedDiet. Each
question was scored 0 or 1. The final score ranged from 0 to 14.
The greater the score obtained from the questionnaire, the greater
the adherence to the MedDiet. Dichotomous variables of
adherence to the MedDiet and nutrient intake were created using
as cut-off points the sample means. Physical activity was estimated
by the Minnesota Leisure Time Physical Activity Questionnaire,
validated for its use in Spanish subjects [47,48].
Weight and height were measured with calibrated scales and a
wall-mounted stadiometer, respectively. BMI was calculated as
weight in kilograms divided by the square of height in meters.
DNA Extraction and Genotyping
At baseline, blood samples were obtained from each participant
after an overnight fast and were frozen at 280uC and shipped to
central laboratories for analyses [35]. Genomic DNA was
extracted from buffy-coat with the MagNaPure LC DNA Isolation
Kit (Roche Diagnostics, Mannheim, Germany). The MC4R
rs17782313 and FTO rs9939609 polymorphisms were genotyped
on a 7900HT Sequence Detection System (Applied Biosystems,
FosterCity, CA, USA) using fluorescent allelic discrimination
TaqManTM assays. The calling rate for both polymorphisms was
.95%. For quality control purposes, 5% of samples were
randomly selected samples and genotyped a second time. There
were no discrepancies between the two results.
Statistical Analyses
Chi-square tests were used to test differences between observed
and expected genotype frequencies, assuming Hardy–Weinberg
equilibrium, and to test differences in percentages. Genetic
variables were tested using co-dominant models of the polymor-
phisms individually. In addition, an additive genetic score was
created from the FTO and the MC4R polymorphism so that the
presence of each of variant allele for each polymorphism was
scored as one point according to the work of Cauchi et al [13].
The range of values of this aggregate score variable was from 0
(homozygous subjects for non-variant alleles) to 4 points (homo-
zygous subjects for the variant alleles both at the FTO and MC4R
genes). In addition, due to the low prevalence of homozygous
subjects for the variant alleles, a grouped score variable was
created grouping the categories of 3 and 4 points as previously
described [13]. We used t and ANOVA tests to compare crude
means of obesity indexes across genetic categories. Multivariate
adjustments for comparisons of continuous variables were carried
out by generalized linear models. Models were first adjusted for
age, sex, center and diabetes. Additional adjustments for energy
intake, physical activity, adherence to the MedDiet or BMI were
also carried out as indicated. In addition to the categorical
analysis, the FTO and the MC4R polymorphism were considered
in the co-dominant model as linear terms coded 0, 1, or 2 (additive
effect), depending of the number of variant alleles with the
homozygote wild-type coded as 0. The regression coefficient (B)
and the 95% confidence interval (CI) was estimated for each
polymorphism. This coefficient indicates the change of Y for each
variant allele of the tested polymorphism. Likewise, the aggregate
score was also considered as a linear term coded as 0, 1, 2, 3, or 4
depending on the number of variant alleles. The corresponding B
and 95%CI for the aggregate score was also estimated in the
unadjusted and adjusted regression models.
Dichotomous variables for dietary variables and physical
activity were created using as cut-off the sample means. Alcohol
intake was square-root transformed for statistical testing. Logistic
regression methods were also used to estimate the associations of
the MC4R rs17782313 and FTO rs9939609 polymorphisms to
predict obesity prevalence and to adjust for confounders as
indicated. In addition to the categorical analysis, the FTO and the
MC4R polymorphism were considered in the co-dominant model
as linear terms coded 0, 1, or 2 (allele dosage effect), depending of
the number of variant alleles with the homozygote wild-type coded
as 0. The regression coefficient (B) and the 95% confidence
interval (CI) was estimated for each polymorphism. This
coefficient indicates the change of Y for each variant allele of
the tested polymorphism. Likewise, the aggregate score was also
considered as a linear term coded as 0, 1, 2, 3, or 4 depending on
the number of variant alleles. The corresponding B and 95%CI for
the aggregate score were also estimated in the unadjusted and
adjusted regression models.
The homogeneity of the effects by sex was also statistically tested
using the likelihood ratio test. To test the interaction between the
MC4R rs17782313, the FTO rs9939609 polymorphisms or their
score variable and physical activity, adherence to MedDiet or the
other dietary variables, separated multivariate regression models
including the corresponding main effects and interaction terms in
addition to the potential confounders, were fitted. The likelihood
ratio test was used to obtain the P values for interactions. Stratified
analyses were also carried out. Statistical analyses were performed
with the SPSS package, version 15.0 (SPSS, Chicago, IL). All tests
were two-tailed and P values ,0.05 were considered statistically
significant.
Power calculations were performed using QUANTO software,
v.1.2.4 [49] and Power and Sample Size Calculation (biostat.mc.-
vanderbilt.edu/wiki/Main/PowerSampleSize). Initial sample size
estimations were undertaken assuming an allele frequency for the
minor FTO and MC4r alleles of 0.43 and of 0.23, respectively and
the parameters from the meta-analysis by Frayling et al [1] for the
FTO (a 31% per-allele increase in the odds of being obese) and the
parameters from the meta-analysis by Loos et al [2] for the MC4R
(a 12% per-allele increase in the odds of being obese), respectively.
To detect these reported effects our sample size (n = 7,019) had a
power higher that 80% (alpha-level = 0.05). Our study was
adequately powered (.80%) to detect as statistically significant a
7% per-allele increase in the OR for obesity for the additive effects
of both polymorphism in the aggregate score in the population as a
whole. The power to detect a statistically significant gene-
environment interaction effect higher than OR 1.20 in the logistic
regression model (using a dichotomous environmental variable
based on the population mean) was .95% for the FTO (additive
effects) and .80% for the MC4R. However, as the gene-
interaction effect of the MC4R was 1.10, the power to detect
this interaction as statistically significant was ,50%. For the
aggregate score, the power to detect the above described additive
gene-environment interaction effects in determining obesity was
.80%. For power calculation in the linear regression analysis, we
considered the magnitude of the gene-environment interaction,
and according to Luan et al [50] an interaction was considered to
be relevant in magnitude when the ratio of the two regression
slopes [B1 for the genetic variable as additive in the first versus the
second (B2) stratum was at least 2]. With a sample size of 7019
individuals our study has a power.80% to detect this interaction
effect for the different outcomes analyzed. Finally, this number of
study subjects allowed us a power.90% to detect as statistically
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significant mean differences of dietary intake by genotype based on
previously reported significant studies [17–19,24].
Results
Table 1 shows demographic, clinical, lifestyle and genetic
characteristics of the 7,052 participants in the PREDIMED study
at baseline depending on the FTO rs9939609 and the MC4R
rs17782313 polymorphisms. Because of the selection criteria, the
prevalence of obesity was high (46.8%). The mean (6SD) of
adherence to the MedDiet was 962 points on the scale of 0 to 14
points in the whole populations. Genotype frequencies did not
deviate from Hardy-Weinberg equilibrium expectations for either
polymorphisms (P = 0.709 for the FTO rs9939609 and P = 0.637
for the MC4R rs17782313). The aggregate score of the two
polymorphisms had a prevalence of 20.6% for zero points
(homozygous subjects for non-variant alleles); 40.9% for 1 point
(subjects with one variant allele either at FTO or MC4R; 29.2% for
2 points (subjects with two variant alleles), 8.5% for 3 points
(subjects with 3 variant alleles) and 0.8% for 4 points (homozygous
subjects for the variant alleles both at the FTO and MC4R genes).
As the number of subjects with a score of 4 points was very low, a
new score-grouped variable was created grouping the categories of
3 and 4 points.
Association between the FTO rs9939609 and MC4R
rs17782313 Polymorphisms and Anthropometric
Variables at Baseline
On analyzing the population as a whole we found a statistically
significant association between the FTO polymorphism and body-
weight, BMI and waist circumference so that carriers of the variant
allele (A) presented statistically significant higher mean values than
homozygous subjects for the major allele (Table 2). These
associations were statistically significant in the unadjusted analysis
and remained statistically significant even after multivariate
control for sex, age, center, diabetes, total energy intake and
physical activity (fully adjusted model). The regression coefficient
(B), assuming additive effects of the variant allele of FTO were also
statistically significant for body-weight, BMI and waist circumfer-
ence. For BMI, we observed an increase of 0.17 kg/m2 (95%CI:
0.05–0.30) for each additional variant allele. This increase,
although statistically significant was not clinically relevant. On
stratifying by sex (data not shown), this association was of greater
magnitude in women than in men. However, the interaction terms
between the FTO polymorphism and sex did not reach statistical
significance for any of the anthropometric measurements analyzed
(P.0.05 for all of them). With regard to the MC4R polymorphism,
its association with BMI and waist circumference was of lower
magnitude than for FTO. Although a trend was observed for
greater values of BMI and waist circumference in homozygous
subjects for the variant allele (C-allele), statistical significance was
not reached in the total population (Table 2). However, we
obtained statistically significant results for body-weight (0.60 kg
per-variant allele; 95% CI: 0.17–1.03) and for height (0.3 cm per-
variant allele; 95%CI: 0.01–0.05) in the adjusted analysis.
Although subjects carrying variant alleles for the MC4R polymor-
phism were also significantly taller (P = 0.031) than their counter-
parts, the magnitude of the effect was very small. On analyzing the
effects of these polymorphisms on obesity we found similar results
(Table 2). The FTO polymorphism was significantly associated
with a higher prevalence of obesity (a 10% per-allele increase in
the odds of being obese; 95%CI: 2%–17%). Homozygous subjects
with the variant FTO allele conclusively demonstrated a 20%
higher risk for obesity (model adjusted for sex, age, center,
diabetes, total energy intake, and physical activity; OR 1.20, 95%
CI 1.04–1.38). There was a suggestion that homozygous subjects
Table 1. Demographic, clinical, lifestyle and genetic characteristics of the study participants according to the FTO and the MC4R
polymorphisms at baseline*.
FTO rs9939609 (n=7,052) MC4R rs17782313 (n=7,019)
TT (n =2329) TA (n =3434) (AA=1289) TT (n =4336) TC (n =2553) (CC=330)
Age (years) 67.0 (6.2) 67.1 (6.3) 66.6 (6.1) 66.9 (6.2) 67.1 (6.2) 66.7 (6.4)
Adherence to the Mediterranean diet (points) 8.6 (1.9) 8.7 (2.0) 8.7 (1.9) 8.7 (2.0) 8.7 (2.0) 8.6 (1.9)
Energy intake (kcal/d) 2288.2 (616.1) 2277.3 (606.4) 2250.8 (593.9) 2274.3 (607.1) 2279.2 (611.4) 2309.4 (593.0)
Physical activity** (kcal/d) 228.7 (234.6) 235.2 (241.7) 225.8 (245.3) 231.4 (239.5) 235.1 (242.6) 217.5 (240.4)
Men (%) 42.6 42.7 42.7 42.9 42.8 40.3
Current smokers (%) 14.2 13.9 14.3 13.6 14.9 14.8
Diabetes (%) 47.3 49.0 50.1 48.5 48.8 49.1
Hypertension (%) 82.7 82.8 82.1 82.3 83.4 82.1
Dyslipidemia(%) 72.9 71.8 72.0 72.4 71.9 71.2
Obesity (%) 45.1 46.6 50*** 46.4 46.9 49.4
FTO rs9939609: TT (%) 62.0 32.9 5.1
FTO rs9939609: TA (%) 61.7 33.7 4.6
FTO rs9939609: AA (%) 61.5 34.3 4.2
MC4R rs17782313: TT (%) 33.4 48.5 18.1
MC4R rs17782313: TC (%) 32.5 48.8 18.6
MC4R rs17782313: CC (%) 35.2 48.3 16.5
*: Values are means and standard deviations (SD) for continuous variables or percentages for categorical variables.
**: Leisure time physical activity.
***: Statistically significat differences (P,0.05) among genotypes.
doi:10.1371/journal.pone.0052344.t001
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with the variant M4CR allele had a 12% higher risk for obesity but
this finding was not conclusive (OR: 1.12, 95% CI 0.89–1.41).
Although our study was adequately powered to detect the effect
reported by Loos et al [2] for the MC4R, as finally the magnitude
of the effect in our population was lower than that initially
expected, our study was unpowered (,80%) to detect as
statistically significant the small effect found for the MC4R in the
whole population.
On creating the aggregate score variable for the two polymor-
phisms, we observed that the higher the number of risk alleles, the
higher the average BMI (Figure 1) and waist circumference (not
shown), reaching statistically significant results (with a increase of
B6SE: 0.1660.05 kg/m2; P = 0.001, per-variant allele for BMI
and B6SE: 0.4360.13 cm; P = 0.001, per-variant allele for waist
circumference in the adjusted model). Likewise, on considering the
aggregate score variable a statistically significant association with
obesity was found. In the fully adjusted model (sex, age, center,
diabetes, total energy intake and physical activity, each variant
allele (FTO or MC4R) of the additive score increased the odds of
Table 2. Association between the FTO and the MC4R polymorphisms and anthropometric measures. Crude means, odds ratio (OR)
and unadjusted and adjusted* regression coefficients (B).
FTO or MC4R
genotypes
11 12 22 Crude Adjusted*
Mean SD Mean SD Mean SD P1 B (95% CI) B (95% CI) P2
FTO rs9939609
TT (n = 2329) TA (n = 3434) (AA = 1289)
Weight (kg) 76.4 (11.8) 76.7 (11.9) 77.7 (12.3) 0.008 0.57 (0.18, 0.96) 0.47 (0.11, 0.82) 0.011
Height (cm) 160.0 (0.1) 160.0 (0.1) 160.0 (0.1) 0.739 0.001 (20.003, 0.005) 0.000 (20.002, 0.002) 0.881
BMI (kg/m2) 29.8 (3.8) 29.9 (3.8) 30.3 (4.1) 0.006 0.20 (0.06, 0.34) 0.17 (0.05, 0.30) 0.007
Waist (cm) 99.9 (10.8) 100.5 (10.4) 101.2 (10.5) 0.005 0.59 (0.24, 0.94) 0.53 (0.19, 0.87) 0.003
Obesity, OR (95% CI) 1 (ref.) 1.06 (0.96–1.18) 1.22 (1.07–1.40) 0.016 1.10 (1.03–1.17) 1.10 (1.02–1.17) 0.014
MC4Rrs17782313
TT (n = 4336) TC (n = 2553) (CC = 330)
Weight (kg) 76.5 (11.8) 77.1 (12.1) 77.8 (12.2) 0.079 0.56 (0.09, 1.03) 0.60 (0.17, 1.03) 0.008
Heigh (cm) 159.9 (0.1) 160.0 (0.1) 160.1 (0.1) 0.481 0.003 (20.001, 0.007) 0.003 (0.001, 0.005) 0.031
BMI (kg/m2) 29.9 (3.8) 30.1 (3.8) 30.4 (4.1) 0.098 0.14 (20.02, 0.30) 0.13 (20.02, 0.28) 0.119
Waist (cm) 100.3 (10.4) 100.7 (10.8) 100.5 (11.1) 0.309 0.28 (20.15, 0.71) 0.30 (20.11, 0.71) 0.186
Obesity, OR (95% CI) 1 (ref.) 1.02 (0.91–1.41) 1.13 (0.91–1.41) 0.561 1.04 (0.96–1.13) 1.03 (0.95–1.12) 0.454
Values are means and standard deviations (SD), odds ratio (OR) and 95% confidence intervals (CI) or regression coefficients (B) and 95% CI.
1: Unadjusted P values for the polymorphisms for the comparison of means or OR as categorical (three categories).
B: Regression coefficient per-variant allele effects (genotypes coded as 0, 1 and 2 according to the number of minor alleles; additive effects).
*: Models adjusted for sex, age, center, diabetes, total energy intake and physical activity.
2: P-values obtained in the adjusted regression models considering additive effects for the polymorphisms.
doi:10.1371/journal.pone.0052344.t002
Figure 1. Association between the aggregate genetic score of the FTO rs9939609 andMC4R rs17782313 and body mass index (BMI).
Multivariate adjusted means. Error bars: SE of means. 0 points (non-variant alleles); 1 point (one variant allele either at FTO or MC4R; 2 points (two
variant alleles), 3 points (3 variant alleles) and 4 points (4 variant alleles). P1: unadjusted P-value for the comparison of means; P2: adjusted for sex, age,
center, diabetes, energy intake and physical activity.
doi:10.1371/journal.pone.0052344.g001
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obesity by 7% (OR = 1.07; 95%CI: 1.01–1.13) for the continuous
aggregate score variable).
Gene-physical Activity Interaction between the FTO
rs9939609 and MC4R rs17782313 Polymorphisms on
Determining Anthropometric Variables
We found a relevant statistically significant interaction between
the FTO rs9939609 polymorphism and leisure time physical
activity on BMI (P-interaction = 0.010) that remained statistically
significant (P-interaction = 0.015) in the multivariate adjusted
model (Figure S1A). Thus, in subjects with high leisure time
physical activity (higher than the sample mean, 230 kcal/d) we
did not detect a statistical significant association between the
FTO polymorphism and BMI (mean6SE: 29.560.1 kg/m2 in
TT, 29.360.1 kg/m2 in TA and 29.560.2 kg/m2 in AA;
P = 0.689). However, when physical activity was low, we did
find a significant association between the FTO rs9939609 variant
allele and higher BMI (mean6SE: 29.960.1 kg/m2 in TT,
30.360.1 kg/m2 in TA and 30.760.2 kg/m2 in AA; P = 0.001).
Likewise, a similar statistically significant interaction (P-interac-
tion = 0.005 in the fully adjusted model) was observed for waist
circumference (Figure S1B). Thus, when physical activity was
high (higher than the sample mean) we did not detect a
statistically significant association between the FTO polymor-
phism and waist circumference (mean6SE: 99.560.4 cm in TT,
99.660.3 cm in TA and 99.460.5 cm in AA; P = 0.737).
However, when physical activity was low, we did find a
significant association between the FTO rs9939609 variant allele
and higher waist circumference (mean6SE: 100.260.4 cm in
TT, 101.160.3 cm in TA and 102.360.5 cm in AA; P,0.001).
Despite not finding a similar interaction between the MC4R
polymorphism and physical activity in determining anthropo-
metric variables (P-interaction = 0.485 for BMI and P-interac-
tion = 0.151 for waist circumference), we found a statistically
significant interaction between physical activity and the aggre-
gate score of both polymorphisms on both BMI (P-interac-
tion = 0.026) (Figure 2A) and waist circumference (P-interac-
tion = 0.014) (Figure 2B).
On considering obesity (Table 3) we also found a statistically
significant interaction between physical activity and the FTO
polymorphism (P-interaction = 0.007 for linear allelic effects),
that was more significant when the aggregate genetic score
variable was analyzed (P-interaction = 0.005 for lineal allelic
effects). This interaction effect was clinically relevant as the
magnitude of the association was different between the strata.
Thus, when physical activity was low, the FTO polymorphism
and the aggregate score were significantly associated with higher
obesity risk in carriers of the variant allele (a 17% per-allele
increase; 95%CI: 7–27 and a 12% per-allele increase; 95%CI: 5–
20 in the OR of obesity, respectively). However, when physical
activity was high, the FTO polymorphism or the aggregate score
were not associated with higher odds of obesity (P = 0.956 and
P = 0.376, respectively), suggesting that a high level of physical
activity is likely to overcome the detrimental effects of genetic
predisposition to obesity even in a high-risk population. This
observation was not due to a lack of power to detect statistically
significant differences in the stratum of high physical activity for
which similar effects than for the low strata were detectable, but
the magnitude of the OR was very low and even in the opposite
direction (lower than 1).
Gene-diet Interactions between the FTO rs9939609 and
MC4R rs17782313 Polymorphisms in Determining
Anthropometric Variables
For the FTO polymorphism we did not find statistically
significant interactions with the MedDiet on BMI (P-interac-
tion = 0.614) or on waist circumference (P-interaction = 0.229), but
the results obtained are compatible with the so-called ‘‘biological
interaction’’. That is to say the FTO polymorphism does not
present genetic determinism on BMI or waist circumference.
Homozygous subjects for the risk-allele may have higher or lower
BMI or waist circumference depending on their greater (above the
sample mean: 9 points) or lesser adherence to the MedDiet
(Figure S2A and S2B). Hence, AA subjects (homozygous for the
obesity risk allele) with low adherence to the MedDiet had a
statistically significant higher BMI than AA individuals with high
adherence (mean6SE: 30.560.2 kg/m2 vs 29.760.2 kg/m2,
respectively; P = 0.008 in the adjusted model). Likewise, mean
waist circumference was statistically higher in AA subjects with low
adherence to the MedDiet in comparison with AA subjects with
high adherence (mean6SE: 102.560.4 cm vs 100.560.4 cm,
respectively; P = 0.001 in the adjusted model). These effects can be
considered clinically relevant in magnitude. Moreover, for waist
circumference, higher adherence to the MedDiet significantly
reversed the genetic effect. Thus, average waist circumference in
AA subjects having high adherence to the MedDiet was
significantly lower than average waist circumference in TT
subjects with low adherence (mean6SE: 100.460.4 cm vs
101.560.3 cm, respectively; P = 0.033).
Similar results were observed when analyzing the aggregate
score of both polymorphisms on BMI (Figure 3A) or waist
circumference (Figure 3B). Although we did not obtain
statistically significant interactions between adherence to the
MedDiet and the aggregate score on BMI (P-interaction = 0.844)
or on waist circumference (P-interaction = 0.981), we observed a
‘‘biological interaction’’. Despite we did not find statistically
significant differences in the slopes of the aggregate score in the
two strata of adherence to MedDiet (B1:0.19; 95%CI: 0.05–0.34
in the low strata vs B2:0.16; 95%CI: 0.02–0.29 in the high
strata) and the B1/B2 ratio was ,1.2 (absence of a statistically
significant interaction), we clearly observed that the BMI of
individuals with higher genetic risk will depend on their greater
o lesser adherence to the MedDiet (‘‘biological interaction’’).
Carriers of 3 or 4 variant alleles had significantly higher BMI
when adherence to the MedDiet was low in comparison with
their counterparts having a higher adherence (mean6SE:
30.660.2 vs 29.860.2 kg/m2, respectively; P = 0.021). Interest-
ingly, high adherence to the MedDiet in individuals genetically
susceptible (carriers of 4 or 3 variant alleles) counterbalanced
their genetic predisposition to higher BMI, exhibiting similar
average BMI than individuals with no risk alleles and lower
adherence to the MedDiet (mean6SE: 29.860.2 vs
30.060.2 kg/m2, respectively; P = 0.502). For waist circumfer-
ence we observed similar results. Carriers of 3 or 4 variant
alleles had significantly higher waist circumference than their
counterparts when adherence to the MedDiet was low vs high
(mean6SE: 102.360.6 vs 100.760.5 cm, respectively;
P = 0.038).
Association between the FTO rs9939609 and MC4R
rs17782313 and Alcohol and Food Intake
We did not observe any significant association between the
FTO or the MC4R polymorphisms and food intake (Table S1).
Interestingly we found statistically significant associations
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between both polymorphism and total alcohol intake as well as
with wine or beer (lower alcohol consumption in subjects
carrying the variant alleles). On analyzing the aggregate score
variable (Table 4), we did not obtain statistically significant
associations with energy, macronutrients or food groups,
however the association with alcohol consumption was higher
and remained statistically significant even after multivariate
adjustment for sex, age, center, diabetes, total energy intake,
physical activity and adherence to the MedDiet (Figure 4A).
Moreover, it remained statistically significant even after adjust-
ment for BMI (B =20.57 g/d per-variant allele; 95%CI: 20.89,
20.25). Per types of alcoholic beverages, we obtained similar
Figure 2. Statistical interaction between the aggregate score (grouped) of the FTO rs9939609 and MC4R rs17782313 and physical
activity on BMI (A) or waist circumference (B). Adjusted means (n = 7,019) of BMI or waist circumference depending on the aggregate score (0,
1, 2, 3 or 4 variant alleles) according to the strata of physical activity (below and above 230 kcal/d). Means were adjusted for sex, age, center, diabetes
and total energy intake. P values for the interaction terms were multivariate adjusted. In the stratified analysis by physical activity, P values for mean
comparisons between genotypes in the low (P1) and high strata (P2) were multivariate adjusted. Error bars: SE of means.
doi:10.1371/journal.pone.0052344.g002
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results (less consumption in carriers of the variant alleles) for the
most consumed alcoholic beverages in this population (wine and
beer). Interestingly, when instead of considering alcohol
consumption in g/d, we considered subjects as or non-drinkers
or drinkers (moderate or high consumption), we also obtained a
statistical significant association between the aggregate score and
drinking habits. Thus, for the whole population, the prevalence
of non-drinkers was higher in subjects with 4 variant alleles in
comparison with the prevalence of non-drinkers in subjects with
zero variant alleles (43.4% vs 36.5%, respectively; P-
trend = 0.01). Likewise, prevalence of subject with high-alcohol
consumption was higher in subjects with zero variant alleles
(14.5%) than in those with 4 variant alleles (5.7%); P-
trend = 0.01). These results were more relevant in men
(Figure 4B), in which alcohol consumption was higher than
in women. Thus, prevalence of non-drinkers was 28.6% in
subjects with 4 variant alleles (vs 15.1% in non-variant allele
carriers), and prevalence of men with high-alcohol consumption
was 27% in non-drinkers (vs 14.3% in men with 4 variant
alleles). These differences can be considered clinically relevant.
Discussion
Although the magnitude of the effect in the whole sample was
lower that that reported for the general population [1], in this
study undertaken in elderly subjects we have found that the FTO
rs9939609 polymorphism was significantly associated with higher
BMI, waist circumference and obesity prevalence, our results
coinciding with previous investigations [1,5–11]. However, the
MC4R rs17782313 polymorphism did not reach the statistical
significance as it had a lesser effect in this population and, even
though a similar trend was observed. While several studies have
reported statistically significant associations between the MC4R
rs17782313 and BMI or obesity [2,24,25,51], there are also studies
that did not find a significant association [9,52] or found stronger
associations with weight than BMI [11] and even studies that have
reported an association with higher height [9,53,54] and that this
association may mask the effects on BMI despite being associated
with higher weight. Our results are in agreement with this
observation as we found statistically significant differences in
weight and height (although very small in magnitude for height).In
agreement with other studies [12,13] we have also found additive
effects of these polymorphisms in this population. We observed
Table 3. Association of the FTO, MC4R and the combined score (FTO and MC4R polymorphisms) with obesity. Stratified
multivariate* logistic regression analysis according to physical activity.
Physical activity (PA)
Low (,230 kcal/d) High (.=230 kcal/d)) P2 for interaction
OR 95% CI OR 95% CI Genotype6PA
FTO rs9939609 (n = 7,052)
TT 1.00 (reference) 1.00 (reference)
TA 1.12 (0.98–1.29) 0.95 (0.79–1.14)
AA 1.39 (1.16–1.65) 0.92 (0.73–1.16)
P1 = 0.001 P1 = 0.743
Variant allele effects**
(Per-A allele) 1.17 (1.07–1.27) 0.96 (0.85–1.07) 0.007
MC4R rs17782313 (n = 7,019) 0.519
TT 1.00 (reference) 1.00 (reference)
TC 1.05 (0.92–1.20) 0.94 (0.79–1.11)
CC 1.19 (0.89–1.58) 0.99 (0.67–1.48)
P1 = 0.412 P1 = 0.758
Variant allele effects**
(Per-C allele) 1.07 (0.96–1.18) 0.96 (0.78–1.09) 0.251
Aggregate score (FTO/MC4R) 0.008
TT and TT (0) 1.00 (reference) 1.00 (reference)
TA or TC (1) 1.06 (0.90–1.25) 0.81 (0.65–1.01)
TA and TC or AA or CC (2) 1.14 (0.96–1.36) 0.91 (0.72–1.14)
Otherwise (3 or 4 variants) 1.58 (1.24–2.01) 0.75 (0.54–1.05)
P1 = 0.001 P1 = 0.173
Variant allele effects***
(Per-allele increase: 1,2,3,or 4) 1.12 (1.05–1.20) 0.96 (0.87–1.05) 0.005
*: Models adjusted for sex, age, center, diabetes, total energy intake and leisure time physical activity.
**: For the estimation of the variante allele efects a variable indicating the number of variant alleles (0, 1 or 2) was created for FTO and MC4R.
***: For the estimation of the variant allele effect of the aggregate score a variable indicating the number of combined variant alleles (0, 1, 2, 3 or 4) was created.
P1: P-value obtained for the global effect of the polymorphism in the multivariate logistic regression models.
P2: P-value for the interaction term between physical activity polymorphism and the corresponding polymorphism in the logistic regression model.
CI: Confidence interval.
doi:10.1371/journal.pone.0052344.t003
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that the aggregate score of both was associated with higher BMI,
waist circumference and obesity prevalence with higher statistical
significance and higher magnitude of the effect than the
independent polymorphisms.
Interestingly, the magnitude of effects of the FTO and MC4R
polymorphisms were not homogeneous in the whole population.
Regarding interactions of these polymorphisms with lifestyle
variables, many studies have analyzed the statistical interaction
of the FTO polymorphism with physical activity obtaining some
Figure 3. Interaction between the aggregate score (grouped) of the FTO rs9939609 and MC4R rs17782313 and adherence to the
Mediterranean Diet (AdMedDiet) on BMI (A) or waist circumference (B). Adjusted means (n = 7,052) according and to the strata of
AdMedDiet (below and above 9 points). Means were adjusted for sex, age, center, diabetes, total energy intake and physical activity. P values for the
interaction terms were multivariate adjusted. In the stratified analysis by AdMedDiet, P values for mean comparisons of BMI or waist circumference
between genotypes were multivariate adjusted (P1 for the low AdMedDiet and P2 for high). Error bars: SE of means.
doi:10.1371/journal.pone.0052344.g003
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different results depending on the population
[8,12,22,27,28,30,32,55]. However, a recent meta-analysis includ-
ing 218,166 adults and 19,268 children [29] concluded that there
was a consistent statistically significant interaction between the
FTO rs9939609 polymorphism and physical activity on obesity
risk. Thus, in sedentary subjects the association of the FTO
polymorphisms with higher BMI or obesity risk was greater in
magnitude than in active subjects. In agreement with these results,
we also found a consistent statistically significant interaction
between the FTO rs9939609 polymorphism and leisure time
physical activity in determining BMI, waist circumference and
obesity prevalence, so that the association between the FTO-risk
allele and higher BMI or obesity prevalence disappeared in active
subjects and was increased in magnitude of the effect and clinical
significance in subjects with low physical activity. We did not find
any significant interaction between physical activity and the MC4R
rs17782313 on BMI, waist circumference or obesity, but observed
a similar trend. A lack of power to detect the statistical significance
was identified for the MC4R polymorphism taking into account the
lower prevalence of the risk-allele and the lower magnitude of the
effect of this polymorphism. However, on considering the
aggregate score of the MC4R rs17782313 and FTO rs9939609,
we did observe a statistically significant interaction both for BMI
and for obesity. As far as we know this is the first time that a
statistically significant interaction between the aggregate score of
the FTO and the MC4R polymorphisms and physical activity on
BMI and obesity is reported. Moreover, the magnitude of the
effect of this interaction was strong and can be considered as
clinically relevant.
With regard to the modulation of the effects of these
polymorphisms by diet, there are few studies that have analyzed
it in comparison with physical activity, and the consistency level is
still low [22,24,32–35,56,57,58]. Sonestedt et al [32] reported a
statistically significant interaction between diet and the FTO
rs9939609 polymorphism on BMI and found that a high total fat
and a low carbohydrate intake boosted the effects of this
polymorphism. In another study [22], we concluded that
saturated fatty acids were those that presented a more statistically
significant and clinically relevant interaction with the FTO
polymorphism in determining BMI in two American populations.
Phillips et al [35] also found a significant interaction with
saturated fat intake, replicating our previous findings. However,
Vimaleswaran et al [33], analyzing data from five European
countries reported no statistically significant interaction between
the FTO rs9939609 and dietary fat, protein or carbohydrate on
BMI. Regarding the MC4R rs17782313, the number of studies
Figure 4. Association between the FTO rs9939609 and MC4R rs17782313 and alcohol intake in g/d (A) or drinking categories (B).
Multivariate adjusted means of alcohol consumption depending on the genetic score of both polymorphisms (A) for the whole population (n = 7,019)
or drinking categories (B) in men (n = 2,995). P1: unadjusted; P2: adjusted for sex, age, center, diabetes, total energy intake and physical activity. Error
bars: SE of means.
doi:10.1371/journal.pone.0052344.g004
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examining gene-diet interactions on anthropometric variables is
very scarce [24]. Qi et al [24] reported no significant interac-
tions between the MC4R rs17782313 polymorphism and dietary
intake on BMI in The Nurses’ Health Study. In our Mediter-
ranean population we did not find a statistically significant
interaction of the FTO rs9939609 or the MC4R rs17782313
polymorphisms with either total fat or saturated fat intake (data
not shown). This is possible due to the fact that we were dealing
with a high overall adherence to the MedDiet population in
which in general there is a low saturated fat intake and a high
MUFA intake from olive oil. We hypothesized that the low or
high adherence to the overall MedDiet pattern will be more
important than the effect of specific macronutrients. However,
when we analyzed the interaction between the adherence to the
MedDiet and these polymorphisms on anthropometric variables,
we did not find statistically significant gene-diet interactions. The
P-values for the interaction terms were non-statistically signifi-
cant because the effect of the polymorphisms were present
(statistically significant) both in the low and the high strata of
MedDiet adherence [parallel lines (B1 = B2) in Figure 3]. This
was not due to a lack of power to detect the interaction term as
statistically significant but to a true absence of heterogeneity of
genetic effects between the strata. However, as the MedDiet has
also a statistically significant effect on reducing BMI (P,0.05),
we observed statistically significant differences between the
genotypes depending on the adherence to the MedDiet. We
believe that it is important to stress that these observed results
are compatible with the so-called ‘‘biological gene-diet interac-
tion’’ [39,59]. A biological gene-environment interaction situa-
tion takes place when there is an environmental factor capable of
modifying genetic susceptibility and it is independent of the
statistical significance [38,59]. This biological interaction is
opposed to the genetic determinism, in which the genotype
completely determines the phenotype. In the genetic determin-
ism situation, if a subject is a carrier of the risk alleles of the FTO
and the MC4R polymorphisms, such genetic susceptibility would
irreversibly determine the obesity phenotype, and that genetic
influence would be totally independent of lifestyle factors.
However, no genetic determinism will occur when dietary
modulation exists (in this case higher adherence to the MedDiet)
that could modify genetic susceptibility (greater BMI in variant
allele carriers) without the interaction term in the mathematical
model being statistically significant. Supporting our cross-
sectional results, there is an interventional study carried out in
a small sub-sample of the PREDIMED participants [51] showing
that after 3 years of nutritional intervention with MedDiet, A-
allele carriers for the FTO rs9939609 had lower body weight gain
than TT subjects. Therefore, it seems important to reconsider
Table 4. Association between the aggregate score of the FTO rs9939609 and the MC4R rs17782313 polymorphisms and dietary
intake in the whole population. Crude and adjusted analyses.
Aggregate score FTO/MC4R Adjusted*
0 1 2 3 or 4 P1 B (95% CI) P2
Mean SD Mean SD Mean SD Mean SD
Energy intake, kcal/d 2292.2 (620.6) 2273.6 (620.6) 2272.7 (611.1) 2273.8 (583.8) 0.775 26.39 (221.09, 8.30) 0.394
Total fat, g/d 98.8 (31.2) 98.7 (30.2) 99.2 (30.9) 99.2 (29.2) 0.954 20.03 (20.75, 0.69) 0.928
SFA, g/d 25.3 (9.7) 25.2 (8.9) 25.5 (9.4) 25.4 (9.0) 0.734 0.01 (20.22, 0.24) 0.934
MUFA, g/d 49.0 (16.5) 48.8 (15.9) 49.2 (16.3) 48.8 (15.4) 0.858 20.08 (20.44, 0.29) 0.688
PUFA, g/d 15.8 (6.9) 15.9 (7.0) 15.9 (7.1) 16.1 (7.0) 0.865 0.05 (20.13, 0.22) 0.609
Proteins, g/d 92.8 (23.8) 92.7 (23.1) 99.2 (23.4) 93.1 (22.9) 0.949 0.01 (20.58, 0.59) 0.985
Carbohydrates, g/d 242.1 (83.3) 238.8 (80.2) 238.2 (81.7) 240.3 (79.7) 0.528 20.54 (22.50, 1.46) 0.599
Alcohol, g/d 9.1 (15.5) 8.5 (13.8) 8.2 (14.2) 6.8 (11.7) 0.009 20.57 (20.89, 20.25) 0.001
Wine, g/d 62.3 (117.5) 58.4 (107.4) 55.3 (100.7) 47.2 (92.6) 0.019 23.90 (26.38, 21.42) 0.002
Beer, g/d 49.7 (152.3) 45.2 (137.8) 40.6 (40.6) 33.8 (95.9) 0.051 25.47 (28.81, 22.14) 0.001
Adherence to MedDiet 8.6 (1.9) 8.7 (2.0) 8.6 (1.9) 8.6 (2.0) 0.169 0.01 (20.04, 0.05) 0.803
Vegetables, g/d 337.7 (165.5) 338.4 (146.5) 338.6 (148.3) 338.1 (142.7) 0.562 0.46 (23.24, 4.16) 0.807
Fruits, g/d 373.3 (213.6) 369.0 (204.7) 371.8 (208.3) 379.4 (209.8) 0.103 2.79 (22.29, 7.88) 0.282
Legumes, g/d 20.9 (15.5) 21.2 (14.4) 20.3 (11.9) 20.9 (13.1) 0.600 20.19 (20.53, 0.14) 0.244
Cereals, g/d 148.8 (94.4) 145.6 (87.9) 146.7 (89.9) 143.4 (86.0) 0.569 20.70 (22.95, 1.54) 0.540
Dairy products, g/d 374.5 (224.7) 391.2 (227.1) 380.4 (217.1) 386.3 (221.8) 0.870 1.05 (24.49, 6.59) 0.710
Meats, g/d 134.5 (65.6) 132.0 (59.5) 132.5 (57.1) 133.3 (66.8) 0.764 20.48 (21.94, 0.99) 0.521
Fish, g/d 100.9 (49.3) 99.0 (48.2) 100.4 (52.9) 101.1 (66.8) 0.113 0.29 (20.99, 1.57) 0.662
Pastries, g/d 22.9 (31.4) 22.5 (30.4) 22.7 (30.4) 21.7 (27.5) 0.561 20.27 (21.04, 0.50) 0.495
Olive oil, g/d 39.6 (18.2) 39.4 (17.9) 39.4 (18.0) 38.7 (18.4) 0.231 20.25 (20.66, 0.16) 0.238
Nuts, g/d 9.9 (13.7) 11.0 (14.8) 10.3 (13.7) 10.3 (13.1) 0.187 0.06 (20.30, 0.42) 0.761
Values are unadjusted means and standard deviations (SD) or regression coefficients (B) and 95% confidence intervals (CI).
1: Unadjusted P values for the score variable grouped as four categories.
*: Models adjusted for sex, age, center, diabetes, physical activity and body mass index.
2: P values for the B (lineal regression coefficient) corresponding to the aggregate score variable as additive (5 levels coded as 0,1,2,3 or 4 according to the number of
variant alleles and adjusted for sex, age, field center, diabetes, physical activity and body mass index).
doi:10.1371/journal.pone.0052344.t004
Gene-Lifestyle Interactions on Body-Weight
PLOS ONE | www.plosone.org 11 December 2012 | Volume 7 | Issue 12 | e52344
the concept of gene-diet interaction and not to discard the
potential use of other ‘‘biological interactions’’ that could modify
genetic susceptibility without the interaction term in the
mathematical model being statistically significant [36–39,59].
Regarding dietary intake, we did not find a consistent
association of the FTO or the MC4R polymorphisms with total
energy, fat, carbohydrates o protein intake, in agreement with
other studies [21–23,34]. However, we do wish to stress the
finding of an important association with alcohol consumption.
We have observed that carriers of the variant allele, both for the
FTO rs9939609 and the MC4R rs17782313 polymorphisms had
statistically significant lower alcohol consumption than wild-type
subjects. The magnitude of this effect was higher for the
aggregate score and remained statistically significant even after
adjustment for BMI. There are no previous studies on humans
that have reported an association of the MC4R s17782313
polymorphism with alcohol intake although there are several
studies on animals which indicate the great importance of the
MC4R in determining alcohol intake [60–63]. Among them, the
work carried out by Navarro et al [61], showing that in mice,
when given centrally a melanocortin receptor agonist, melanotan-
II reduced ethanol drinking by signalling through the MC4R and
suggested that this association is independent of food intake.
Therefore our results of the association between the MC4R
polymorphism and alcohol intake are novel in humans and
mechanistically supported by results in mice [60–63]. With
regard to FTO some studies have analyzed the influence of
alcohol intake in humans with varying results [64,65]. Among
them we could mention a study carried out in Poland [65] that, in
agreement with our results, also found a lower alcohol intake in
carriers of the variant allele of the FTO rs9939609 polymorphism
[49].
One limitation in our study may be that we have used self-
reported measures of diet and physical activity in place of 24-hour
record of food intake for diet pedometers or accelerometers that
are more objective measures. However, taking into account our
large sample size this was not possible due to the high cost that this
would involve. Moreover, we have specifically validated the semi-
quantitative 137-item food frequency questionnaire [43] as well as
the MedDiet adherence questionnaire in this specific population
obtaining excellent results [46]. On the other hand, the Minnesota
Leisure Time Physical Activity Questionnaire used to measure
physical activity as also validated in men [47] and women [48]
from the Spanish population.
In conclusion, we have confirmed the association of the FTO
rs9939609 polymorphism with higher BMI, waist circumference
and obesity even in a high cardiovascular risk population and
described an additive effect of the FTO rs9939609 and the MC4R
rs17782313 on these obesity-related measures. Moreover, we have
found that these genetic effects can be modulated by lifestyle
variables, the statistical interaction with physical activity and the
biological interaction (not statistically significant) with the adher-
ence to the MedDiet being especially important in magnitude.
Although in this population the FTO and the MC4R polymor-
phisms do not have a relevant association with food intake, their
association with alcohol consumption is outstanding. This is the
first time that an association of both polymorphisms with alcohol
intake in humans is reported, although there are important data
supporting the influence of the MC4R in alcohol intake in animal
models. More studies are needed to replicate and extend these
findings.
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